Us Physicalrapy Stock Z Score

USPH Stock

USD 76.17 0.33 0.43%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out US Physicalrapy Piotroski F Score and US Physicalrapy Valuation analysis.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

As of now, US Physicalrapy's Net Working Capital is increasing as compared to previous years. The US Physicalrapy's current Long Term Debt To Capitalization is estimated to increase to 0.26, while Capital Surpluse is projected to decrease to under 73.5 M. As of now, US Physicalrapy's Other Operating Expenses is increasing as compared to previous years. The US Physicalrapy's current EBIT is estimated to increase to about 71.6 M, while Operating Income is projected to decrease to under 32.2 M.

US Physicalrapy Company Z Score Analysis

US Physicalrapy's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

USPH Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Z Score. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.72	0.88	0.86	0.89	0.98	0.87	0.83	0.98	-0.37	0.63	0.89	-0.3	0.93	0.04	0.08	-0.85	0.74	0.9	0.83	0.63	-0.86	0.88	0.87	0.14	0.78
Total Stockholder Equity	0.99		0.62	0.88	0.8	0.89	0.95	0.91	0.76	0.95	-0.44	0.68	0.84	-0.37	0.89	0.08	-0.01	-0.82	0.72	0.86	0.79	0.6	-0.83	0.88	0.86	0.24	0.8
Net Debt	0.72	0.62		0.75	0.86	0.51	0.82	0.55	0.9	0.65	-0.27	0.38	0.83	-0.25	0.77	0.11	0.15	-0.78	0.57	0.75	0.75	0.57	-0.81	0.53	0.66	-0.11	0.3
Retained Earnings	0.88	0.88	0.75		0.78	0.84	0.86	0.79	0.8	0.8	-0.69	0.81	0.77	-0.65	0.74	0.32	-0.23	-0.7	0.76	0.74	0.84	0.67	-0.91	0.67	0.66	0.0	0.5
Accounts Payable	0.86	0.8	0.86	0.78		0.74	0.92	0.65	0.81	0.86	-0.36	0.53	0.94	-0.3	0.94	0.07	0.02	-0.9	0.57	0.93	0.7	0.48	-0.75	0.7	0.79	-0.01	0.59
Net Receivables	0.89	0.89	0.51	0.84	0.74		0.82	0.7	0.58	0.9	-0.57	0.74	0.72	-0.49	0.73	0.14	-0.21	-0.62	0.72	0.76	0.68	0.55	-0.71	0.78	0.64	-0.01	0.72
Total Liab	0.98	0.95	0.82	0.86	0.92	0.82		0.83	0.89	0.96	-0.32	0.56	0.94	-0.25	0.96	0.02	0.12	-0.91	0.69	0.93	0.82	0.6	-0.85	0.87	0.89	0.11	0.74
Total Current Assets	0.87	0.91	0.55	0.79	0.65	0.7	0.83		0.64	0.78	-0.42	0.65	0.78	-0.38	0.79	0.15	-0.03	-0.78	0.62	0.77	0.74	0.57	-0.79	0.75	0.85	0.56	0.68
Short Term Debt	0.83	0.76	0.9	0.8	0.81	0.58	0.89	0.64		0.76	-0.22	0.4	0.77	-0.18	0.81	0.03	0.25	-0.76	0.61	0.72	0.82	0.61	-0.85	0.69	0.73	-0.15	0.47
Intangible Assets	0.98	0.95	0.65	0.8	0.86	0.9	0.96	0.78	0.76		-0.29	0.56	0.88	-0.21	0.93	-0.05	0.1	-0.84	0.67	0.91	0.74	0.54	-0.76	0.92	0.85	0.08	0.83
Good Will	-0.37	-0.44	-0.27	-0.69	-0.36	-0.57	-0.32	-0.42	-0.22	-0.29		-0.9	-0.3	0.99	-0.22	-0.64	0.83	0.21	-0.38	-0.25	-0.33	-0.25	0.39	-0.18	-0.17	0.01	-0.13
Common Stock	0.63	0.68	0.38	0.81	0.53	0.74	0.56	0.65	0.4	0.56	-0.9		0.51	-0.86	0.47	0.7	-0.64	-0.45	0.53	0.49	0.6	0.47	-0.56	0.45	0.51	0.08	0.51
Long Term Debt	0.89	0.84	0.83	0.77	0.94	0.72	0.94	0.78	0.77	0.88	-0.3	0.51		-0.24	0.96	0.04	0.05	-0.97	0.6	0.97	0.71	0.51	-0.76	0.79	0.88	0.24	0.65
Treasury Stock	-0.3	-0.37	-0.25	-0.65	-0.3	-0.49	-0.25	-0.38	-0.18	-0.21	0.99	-0.86	-0.24		-0.15	-0.64	0.84	0.15	-0.34	-0.18	-0.29	-0.23	0.36	-0.1	-0.1	0.0	-0.02
Property Plant Equipment	0.93	0.89	0.77	0.74	0.94	0.73	0.96	0.79	0.81	0.93	-0.22	0.47	0.96	-0.15		-0.05	0.16	-0.97	0.57	0.97	0.71	0.48	-0.75	0.83	0.92	0.2	0.75
Current Deferred Revenue	0.04	0.08	0.11	0.32	0.07	0.14	0.02	0.15	0.03	-0.05	-0.64	0.7	0.04	-0.64	-0.05		-0.58	-0.01	0.14	-0.03	0.34	0.33	-0.14	-0.1	0.15	-0.07	0.1
Short Term Investments	0.08	-0.01	0.15	-0.23	0.02	-0.21	0.12	-0.03	0.25	0.1	0.83	-0.64	0.05	0.84	0.16	-0.58		-0.11	0.03	0.08	0.16	0.17	-0.12	0.12	0.18	-0.02	0.11
Net Tangible Assets	-0.85	-0.82	-0.78	-0.7	-0.9	-0.62	-0.91	-0.78	-0.76	-0.84	0.21	-0.45	-0.97	0.15	-0.97	-0.01	-0.11		-0.52	-0.95	-0.68	-0.43	0.71	-0.76	-0.92	-0.3	-0.68
Total Permanent Equity	0.74	0.72	0.57	0.76	0.57	0.72	0.69	0.62	0.61	0.67	-0.38	0.53	0.6	-0.34	0.57	0.14	0.03	-0.52		0.59	0.8	0.78	-0.78	0.57	0.5	-0.03	0.42
Long Term Debt Total	0.9	0.86	0.75	0.74	0.93	0.76	0.93	0.77	0.72	0.91	-0.25	0.49	0.97	-0.18	0.97	-0.03	0.08	-0.95	0.59		0.69	0.46	-0.74	0.78	0.87	0.23	0.72
Capital Surpluse	0.83	0.79	0.75	0.84	0.7	0.68	0.82	0.74	0.82	0.74	-0.33	0.6	0.71	-0.29	0.71	0.34	0.16	-0.68	0.8	0.69		0.87	-0.92	0.62	0.74	-0.02	0.56
Deferred Long Term Liab	0.63	0.6	0.57	0.67	0.48	0.55	0.6	0.57	0.61	0.54	-0.25	0.47	0.51	-0.23	0.48	0.33	0.17	-0.43	0.78	0.46	0.87		-0.76	0.45	0.52	-0.05	0.38
Accumulated Depreciation	-0.86	-0.83	-0.81	-0.91	-0.75	-0.71	-0.85	-0.79	-0.85	-0.76	0.39	-0.56	-0.76	0.36	-0.75	-0.14	-0.12	0.71	-0.78	-0.74	-0.92	-0.76		-0.63	-0.68	-0.05	-0.43
Short Long Term Debt	0.88	0.88	0.53	0.67	0.7	0.78	0.87	0.75	0.69	0.92	-0.18	0.45	0.79	-0.1	0.83	-0.1	0.12	-0.76	0.57	0.78	0.62	0.45	-0.63		0.82	0.17	0.82
Net Invested Capital	0.87	0.86	0.66	0.66	0.79	0.64	0.89	0.85	0.73	0.85	-0.17	0.51	0.88	-0.1	0.92	0.15	0.18	-0.92	0.5	0.87	0.74	0.52	-0.68	0.82		0.36	0.85
Net Working Capital	0.14	0.24	-0.11	0.0	-0.01	-0.01	0.11	0.56	-0.15	0.08	0.01	0.08	0.24	0.0	0.2	-0.07	-0.02	-0.3	-0.03	0.23	-0.02	-0.05	-0.05	0.17	0.36		0.23
Capital Stock	0.78	0.8	0.3	0.5	0.59	0.72	0.74	0.68	0.47	0.83	-0.13	0.51	0.65	-0.02	0.75	0.1	0.11	-0.68	0.42	0.72	0.56	0.38	-0.43	0.82	0.85	0.23

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict US Physicalrapy

As per the company's disclosures, US Physicalrapy has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and about the same as Health Care (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.

US Physicalrapy ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.

Environmental

Governance

Social

US Physicalrapy Institutional Holders

Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.

		Shares
Gw&k Investment Management, Llc	2024-12-31	316.2 K
Riverbridge Partners Llc	2024-12-31	310.2 K
Envestnet Asset Management Inc	2024-12-31	299.8 K
Northern Trust Corp	2024-12-31	261.8 K
Bahl & Gaynor Inc.	2024-12-31	260.1 K
Point72 Asset Management, L.p.	2024-12-31	212.9 K
Silvercrest Asset Management Group Llc	2024-12-31	189.1 K
Rockefeller Capital Management L.p.	2024-12-31	188.3 K
Fmr Inc	2024-12-31	165.7 K
Blackrock Inc	2024-12-31	2.3 M
Vanguard Group Inc	2024-12-31	1.1 M

USPH Fundamentals

	Return On Equity	0.0646
	Return On Asset	0.0404
	Profit Margin	0.05 %
	Operating Margin	0.1 %
	Current Valuation	1.42 B
	Shares Outstanding	15.19 M
	Shares Owned By Insiders	1.94 %
	Shares Owned By Institutions	98.06 %
	Number Of Shares Shorted	538.49 K
	Price To Earning	34.35 X
	Price To Book	2.38 X
	Price To Sales	1.75 X
	Revenue	560.55 M
	Gross Profit	146.13 M
	EBITDA	86.91 M
	Net Income	45.6 M
	Cash And Equivalents	48.57 M
	Cash Per Share	3.73 X
	Total Debt	153.6 M
	Debt To Equity	0.57 %
	Current Ratio	1.43 X
	Book Value Per Share	32.39 X
	Cash Flow From Operations	74.94 M
	Short Ratio	4.77 X
	Earnings Per Share	1.84 X
	Price To Earnings To Growth	3.19 X
	Target Price	110.0
	Number Of Employees	4.03 K
	Beta	1.51
	Market Capitalization	1.16 B
	Total Asset	1.17 B
	Retained Earnings	227.26 M
	Working Capital	21.3 M
	Current Asset	60.18 M
	Current Liabilities	19.01 M
	Annual Yield	0.02 %
	Five Year Return	1.01 %
	Net Asset	1.17 B
	Last Dividend Paid	1.76

About US Physicalrapy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

V	Visa Class A
CRM	Salesforce
CRM	Salesforce
MSFT	Microsoft
V	Visa Class A

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out US Physicalrapy Piotroski F Score and US Physicalrapy Valuation analysis.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.76

Earnings Share

1.84

Revenue Per Share

44.107

Quarterly Revenue Growth

0.166

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Us Physicalrapy Stock Z Score

US Physicalrapy Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

USPH Z Score Driver Correlations

US Physicalrapy ESG Sustainability

US Physicalrapy Institutional Holders

USPH Fundamentals

About US Physicalrapy Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY